How COVID Unlocked the Power of RNA Vaccines

How COVID Unlocked the Power of RNA Vaccines
(AP Photo/Kevin Hagen)

It was a Friday afternoon in March 2013 when Andy Geall got the call. Three people in China had just become infected with a new strain of avian influenza. The global head of vaccines research at Novartis, Rino Rappuoli, wanted to know whether Geall and his colleagues were ready to put their new vaccine technology to the test.

Read Full Article »


Comment
Show comments Hide Comments


Related Articles